Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-25-083075
Filing Date
2025-08-26
Accepted
2025-08-26 16:06:49
Documents
6
Period of Report
2025-08-25

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2524261-1_pre14a.htm PRE 14A 923225
2 GRAPHIC lg_enterothera-4c.jpg GRAPHIC 12727
3 GRAPHIC px_25enterotheproxy1pg01-bw.jpg GRAPHIC 285016
4 GRAPHIC px_25enterotheproxy1pg02-bw.jpg GRAPHIC 202221
5 GRAPHIC px_25enterotheproxy1pg03-bw.jpg GRAPHIC 208144
6 GRAPHIC px_25enterotheproxy1pg04-bw.jpg GRAPHIC 202224
  Complete submission text file 0001104659-25-083075.txt   2084854
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37853 | Film No.: 251257642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)